Synergus

This webinar is hosted by IGES medtech.

With the new EU HTA regulation, a process has been established to harmonise the PICO scope for the joint EU HTA evaluation.

• Patient
• Intervention
• Comparator
• Outcomes

The process involves asking all the member states about the appropriate PICO from a policy perspective.

From the experience in both pharma and medical devices, this has led to many different PICO schemes, making the evidence development complex for companies.

How should the study be designed to ensure successful outcomes in reimbursement and HTA processes?

In this session, we’ll cover:

• What is the EU HTA PICO process?
• What insights can be made from the pilot project?
• Clinical and Economic Evidence Requirements across Europe
• The role of the Joint Scientific Consultation
• A review of how the PICO applies to:
  • Germany
  • France
• Recommended actions to help you prepare for these changes.

Speakers:

• Mattias Kyhlstedt
• Michel Verhasselt
• Michael Weisser

Date and time : June 4^th 16:00 CET